E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/12/2020 in the Prospect News Bank Loan Daily and Prospect News Private Placement Daily.

Sorrento Therapeutics repays $120 million term loan with Oaktree

By Wendy Van Sickle

Columbus, Ohio, June 12 – Sorrento Therapeutics Inc. fully repaid its $120 million term loan agreement with Oaktree Capital Management, LP on Friday, according to a news release.

The debt was comprised of an initial $100 million term loan and a $20 million incremental loan.

Sorrento Therapeutics is a San Diego-based clinical stage biopharmaceutical company focused on malignant cancers.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.